251 related articles for article (PubMed ID: 32361310)
1. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
[TBL] [Abstract][Full Text] [Related]
2. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene.
Gao X; Qiu SW; Wang WQ; Kang DY; Su N; Dai P; Yuan YY
Stem Cell Res; 2021 May; 53():102271. PubMed ID: 33714068
[TBL] [Abstract][Full Text] [Related]
3. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
4. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A.
Kung LHW; Sampurno L; Yammine KM; Graham A; McDonald P; Bateman JF; Shoulders MD; Lamandé SR
Stem Cell Res; 2020 Oct; 48():101962. PubMed ID: 33002832
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line from a patient with global development delay carrying DYRK1A mutation (c.1730T>A) and a gene correction isogenic iPSC line.
Ma L; Wu Z; Tang Q; Ji X; Mei Y; Peng T; Xu Q; Zhou W; Xiong M
Stem Cell Res; 2021 May; 53():102305. PubMed ID: 33813175
[TBL] [Abstract][Full Text] [Related]
8. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 gene editing of a SOX9 reporter human iPSC line to produce two TRPV4 patient heterozygous missense mutant iPSC lines, MCRIi001-A-3 (TRPV4 p.F273L) and MCRIi001-A-4 (TRPV4 p.P799L).
Nur Patria Y; Stenta T; Lilianty J; Rowley L; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
Stem Cell Res; 2020 Oct; 48():101942. PubMed ID: 32771907
[TBL] [Abstract][Full Text] [Related]
10. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
[TBL] [Abstract][Full Text] [Related]
11. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9.
Sun X; Zhou X; Dong B; Wang C; Xiao X; Wang Y
Stem Cell Res; 2021 Apr; 52():102230. PubMed ID: 33592566
[TBL] [Abstract][Full Text] [Related]
12. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
Wang H; Luo Y; Li J; Guan J; Yang S; Wang Q
Stem Cell Res; 2022 Apr; 60():102736. PubMed ID: 35247837
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
[TBL] [Abstract][Full Text] [Related]
14. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs.
Li D; Ou M; Zhang W; Luo Q; Cai W; Mo C; Liang W; Dai G; Yin L; Zhu P; Tang D; Dai Y
Front Biosci (Landmark Ed); 2023 Jun; 28(6):131. PubMed ID: 37395026
[TBL] [Abstract][Full Text] [Related]
16. Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9.
Ben Yacoub T; Letellier C; Wohlschlegel J; Condroyer C; Slembrouck-Brec A; Goureau O; Zeitz C; Audo I
Stem Cell Res; 2023 Sep; 71():103166. PubMed ID: 37473460
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
18. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
[TBL] [Abstract][Full Text] [Related]
19. Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient.
Houweling PJ; Coles CA; Tiong CF; Nielsen B; Graham A; McDonald P; Suter A; Piers AT; Forbes R; Ryan MM; Howden SE; Lamandé SR; North KN
Stem Cell Res; 2021 Jul; 54():102429. PubMed ID: 34157503
[TBL] [Abstract][Full Text] [Related]
20. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.
Tsukamoto S; Nakade K; Wakabayashi T; Nakashima K; Takami M; Hemmi Y; Kuramochi Y; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Miwa Y; Hayashi Y
Stem Cell Res; 2021 May; 53():102363. PubMed ID: 34087992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]